See the original post here: ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
See the original post here: ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
Continue reading here: Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
Read more: Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S
More: Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression
See original here: Avalyn Pharma’s CEO Leads Workshop on Clinical Strategy at IPF Summit
Excerpt from: AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
Read more: Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Read the original here: Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
View post: Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023
Read the original here: Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
Recent Comments